Hayat Pharmaceuticals Consulting

Home
United States
Mill Valley, CA
Hayat Pharmaceuticals Consulting

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Hayat Pharmaceuticals Consulting, Medical and health, 536 Shoreline Highway, Mill Valley, CA.

11/20/2025

🌿 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐧𝐠 𝐓𝐡𝐫𝐨𝐮𝐠𝐡 𝐏𝐫𝐨𝐜𝐞𝐬𝐬 𝐂𝐡𝐞𝐦𝐢𝐬𝐭𝐫𝐲
In the field of pharmaceuticals and specialty chemicals, process chemistry plays a key role in connecting discovery to large-scale production. ⚗️
From improving reaction conditions to making processes more efficient and sustainable, process chemistry turns great ideas into practical, real-world solutions. 💡

𝐖𝐡𝐞𝐭𝐡𝐞𝐫 𝐢𝐭’𝐬 𝐚𝐛𝐨𝐮𝐭:
🌎 Reducing environmental impact
⚙️ Scaling up complex reactions
🧪 Fixing production challenges
…the work of a process chemist is always evolving and exciting.

✨ 𝐋𝐞𝐭’𝐬 𝐚𝐩𝐩𝐫𝐞𝐜𝐢𝐚𝐭𝐞 𝐭𝐡𝐞 𝐜𝐫𝐞𝐚𝐭𝐢𝐯𝐢𝐭𝐲 𝐚𝐧𝐝 𝐩𝐫𝐨𝐛𝐥𝐞𝐦-𝐬𝐨𝐥𝐯𝐢𝐧𝐠 𝐭𝐡𝐚𝐭 𝐝𝐫𝐢𝐯𝐞 𝐭𝐡𝐢𝐬 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭 𝐟𝐢𝐞𝐥𝐝!

💬 What challenges or innovations have you experienced in process chemistry? Share your thoughts below — let’s discuss!

11/15/2025

🌿 Innovating Through Process Chemistry
In the field of pharmaceuticals and specialty chemicals, process chemistry plays a key role in connecting discovery to large-scale production. ⚗️
From improving reaction conditions to making processes more efficient and sustainable, process chemistry turns great ideas into practical, real-world solutions. 💡

Whether it’s about:
🌎 Reducing environmental impact
⚙️ Scaling up complex reactions
🧪 Fixing production challenges
…the work of a process chemist is always evolving and exciting.

✨ Let’s appreciate the creativity and problem-solving that drive this important field!

💬 What challenges or innovations have you experienced in process chemistry? Share your thoughts below — let’s discuss!

11/13/2025

🌟 𝐇𝐚𝐲𝐚𝐭 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠 (𝐇𝐏𝐂) 𝐢𝐬 𝐡𝐞𝐚𝐝𝐢𝐧𝐠 𝐭𝐨 𝐒𝐚𝐧 𝐅𝐫𝐚𝐧𝐜𝐢𝐬𝐜𝐨! 🌟

We’re proud to share that our CEO, Dr. Umar Hayat, will be attending the 44th Annual JP Morgan Healthcare Conference from January 12–15, 2026, in San Francisco, California.

This premier global event brings together industry leaders, innovators, and investors shaping the future of healthcare. Dr. Umar Hayat’s participation reflects HPC’s continued commitment to advancing global collaborations, driving impactful partnerships, and contributing to transformative healthcare solutions.

At HPC, we believe in bridging science, strategy, and ex*****on — empowering companies to deliver better health outcomes worldwide.

🤝 Let’s connect during the conference to explore partnership opportunities and innovative approaches to the future of healthcare.

📅 January 12–15, 2026
📍 San Francisco, California
📧 uhayat@hpc-us.com
🌐 www.hpc-us.com

11/11/2025

At Hayat Pharmaceuticals Consulting (HPC), we drive drug development with precision, performance, and purpose—turning scientific ideas into safe, effective, and scalable therapies.
Our expertise covers:
🔬 Innovative Drug Design – translating discovery into viable candidates
💧 Smart Solubility Solutions – boosting bioavailability & stability
🧫 Pre-formulation Expertise – robust material & compatibility studies
📦 Validated Dosage Forms – oral, injectable, inhalation, topical and more
🚀 From Lab to Market – tech transfer, scale-up, and commercialization
By integrating science, innovation, and regulatory insight, HPC accelerates the journey from concept to commercialization.

10/30/2025

At Hayat Pharmaceuticals Consulting (HPC), we believe that true innovation thrives at the intersection of science, strategy, and collaboration.
Our Founder Dr. Umar and Muhammad Aleem are proudly representing HPC at CPHI Frankfurt 2025, where leading minds from across the pharmaceutical ecosystem gather to shape the future of drug development.
From regulatory affairs and quality management to formulation design and clinical strategy, HPC partners with organizations around the world to ensure that every step from concept to commercialization is scientifically sound and strategically aligned.
Events like CPHI provide an incredible opportunity to exchange insights, explore synergies, and build relationships that drive meaningful progress in healthcare.
Together, we’re working to bridge science and solutions transforming innovation into access for patients everywhere.

10/21/2025

We are delighted to share that Hayat Pharmaceuticals Consulting (HPC) will be participating in CPHI Frankfurt 2025, the global hub for pharmaceutical innovation, collaboration, and partnership development.
Join us at booth 4S117 from 28–30 October 2025 to connect with our team!
At HPC, we are passionate about empowering pharmaceutical and biotechnology companies through science-driven consulting, strategic development planning, and regulatory excellence.
Our mission is to bridge the gap between research and commercialization helping innovators navigate complex global frameworks, optimize development strategies, and bring transformative therapies to patients faster and more effectively.
With decades of experience across drug discovery, clinical development, regulatory affairs, and manufacturing intelligence, our experts provide tailored solutions that align innovation with compliance enabling our partners to grow sustainably in an evolving life sciences landscape.
Let’s meet in Frankfurt to discuss how we can shape the future of healthcare together.
📅 28–30 October 2025 | Booth 4S117

10/11/2025

We are excited to announce that Dr Umar represented Hayat Pharma Consulting (HPC) at Bio Japan 2025. At HPC, we provide end-to-end pharmaceutical consulting across the entire drug lifecycle, from regulatory strategy to CDMO selection, manufacturing audits and market-launch readiness.

The meetings in Japan were truly inspiring: Dr Umar engaged with global leaders who are building some of the most impressive innovations in biotech, regulatory affairs and supply-chain resiliency. These conversations reinforce HPC’s mission to help our clients move therapeutic drugs from concept to clinic, delivering safe, effective solutions to patients.

As we continue to build bridges between international expertise and local ex*****on, HPC remains committed to providing strategic, science-driven guidance, whether you’re navigating IND/IMPD filings, technology transfers, manufacturing audits or global regulatory pathways. We’re proud to bring that capability to the world.

10/07/2025

Join Us at CPHI Frankfurt 2025! 🇩🇪
We’re excited to announce that Team Hayat Pharmaceuticals Consulting (HPC) and Trials360 will be participating in CPHI Frankfurt 2025, one of the world’s leading pharmaceutical industry events!
Meet our leadership team:
👤 Dr. Umar Hayat – CEO (uhayat@hpc-us.com)
👤 Muhammad Aleem – Project Management, QA (maleem@hpc-us.com)
👤 Dr. Imran Naveed – Regulatory Manager (drimrannaveed@trials360.com)

📅 28–30 October 2025
📍 Messe Frankfurt | Booth No. 4S117
Let’s connect, collaborate, and explore innovative solutions shaping the future of pharmaceuticals and clinical research.
📩 Book a meeting: uhayat@hpc-us.com
| ☎️ +1-415-686-8822

09/18/2025

We’re excited to share that Hayat Pharmaceutical Consulting (HPC) and Trials360 will be attending BIO JAPAN 2025 at PACIFICO Yokohama from 8–10 October. Our onsite lead, Dr. Umar Hayat (CEO), will be meeting biotechs, pharma teams, CDMOs, and investors to explore end-to-end collaboration—from clinical research ex*****on (protocol and study design, site start-up, monitoring, data and safety oversight) to CMC and quality solutions (route scouting, process development, DS/DP strategy, tech transfer, scale-up, analytical and stability programs, and QMS under GLP/GMP/GDP), as well as global regulatory strategy, submissions, due diligence, and BD/licensing support across the US, EU, and APAC. With integrated CRO + CMC/Regulatory capabilities and leadership experience spanning three decades, we focus on pragmatic, compliance-first delivery that shortens time-to-milestone and moves assets efficiently from bench to bedside—especially in oncology, while remaining modality-agnostic.

If you’ll be in Yokohama and want to connect, message us here or reach
📧 uhayat@hpc-us.com 📞 +1-415-686-8822‬and mention “Bio Japan” in the subject. We look forward to productive conversations and new partnerships.

hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag

09/05/2025

Trials360 & HPC at CTS West Coast 2025 🌍

We are pleased to share that our CEO, Dr. Umar Hayat, will be attending the 18th Annual Clinical Trial Supply West Coast — a premier gathering of global industry leaders and innovators.

This year’s focus, "Mitigating and Planning for Unforeseen Risks in Clinical Supply Chain", addresses one of the most critical challenges in ensuring uninterrupted access to life-saving clinical trial therapies. From regulatory complexities to global disruptions, the discussions will spotlight strategies for resilience, agility, and operational excellence.

Trials360 and HPC look forward to connecting with peers, exchanging knowledge, and exploring opportunities that drive innovation and strengthen clinical supply chain management worldwide.

08/18/2025

Innovating Through Process Chemistry 🌱
In the world of pharmaceuticals and specialty chemicals, process chemistry is the bridge between discovery and large-scale production. From optimizing reaction conditions to enhancing sustainability and efficiency, process chemistry ensures that groundbreaking ideas become practical solutions.
Whether it’s reducing environmental impact, scaling up complex syntheses, or troubleshooting manufacturing challenges, the role of a process chemist is as dynamic as the reactions we design.
Let’s celebrate the ingenuity and problem-solving that drives this critical field!
What challenges have you tackled or admired in process chemistry? Let’s discuss in the comments! 💬 .

08/11/2025

At Hayat Pharmaceuticals Consulting (HPC), we understand that regulatory expectations around L&E assessments are increasing — not just for compliance, but to ensure the safety of drug products across their lifecycle.

Leachables and extractables from container-closure systems, manufacturing components, and packaging can migrate into pharmaceutical products, posing potential health risks. That's why HPC delivers scientifically sound, end-to-end L&E support, ensuring you meet both regulatory expectations and patient safety benchmarks.

🔬 Our Comprehensive L&E Services Include:
✔️ Study Design — tailored to your formulation, packaging, and regulatory pathway
✔️ Risk Evaluation — based on toxicological relevance and product use case
✔️ Data Interpretation — contextualized for clear decision-making
✔️ Regulatory Submissions — aligned with global requirements (FDA, EMA, ICH)

Whether you’re in early-phase development or preparing for product launch, HPC ensures your L&E strategy is robust, compliant, and audit-ready.

Let’s navigate this critical path with precision — together.

📩 uhayat@hpc-us.com
📞 +1-415-686-8822
🌐 www.hpc-us.com

Address

536 Shoreline Highway
Mill Valley, CA
94941

Website

https://hpc-us.com/

Alerts

Be the first to know and let us send you an email when Hayat Pharmaceuticals Consulting posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Hayat Pharmaceuticals Consulting:

Shortcuts

Want your practice to be the top-listed Clinic in Mill Valley?